Dragonfly Announces Clinical Collaboration Exploring Combinations of Dragonfly's DF1001 HER-2 TriNKET® with Gilead's Trodelvy® in two Cancer Indications

Dragonfly Therapeutics, Inc. Massachusetts

View original content:https://www.prnewswire.co.uk/news-releases/dragonfly-announces-clinical-collaboration-exploring-combinations-of-dragonflys-df1001-her-2-trinket-with-gileads-trodelvy-in-two-cancer-indications-302062649.html